NCT03182257 - Study of ONO-7579 in Patients With Advanced Solid Tumors/ NTRK Gene Fusion Positive Advanced Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 12, 2017

Primary Completion Date

January 30, 2018

Study Completion Date

January 30, 2018

Conditions

Solid Tumor

Interventions

DRUG

ONO-7579

ONO-7579 Tablets

Trial Locations (5)

Mount Sinai, New York

Montefiore Medical Center, Lake Success

Greenville Hospital System University Medical Center, Greenville

Mary Crowley Cancer Research Center, Dallas

Beatson West of Scotland Cancer Centre, Glasgow